New drugs of year 2000: The challenges of the clinic and the manager;Novedades terapéuticas del año 2000: Los retos del médico y del gestor

Medicina Clinica

Volumn 116, Issue 12, 2001, Pages 465-468

  Puigventos Latorre F ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; INFLIXIMAB; NEW DRUG; PALIVIZUMAB; TEMOZOLOMIDE; TIROFIBAN;

ARTICLE; ASTROCYTOMA; COST EFFECTIVENESS ANALYSIS; CROHN DISEASE; DRUG COST; GLIOBLASTOMA; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RETINA MACULA DEGENERATION; RHEUMATOID ARTHRITIS; VIRUS INFECTION;

EID: 0040158417     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(01)71871-4     Document Type: Article

References (21)

1. New drug classes: Therapeutic monoclonal antibodies
2. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
3. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial. ATTRACT study
4. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
5. Infliximab for the treatment of fistulas in patients with Crohn's disease
6. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin; One-year results of 2 randomized clinical trials TAP report 1; Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group
7. Inhibition of the platelet glycoprotein IIb-IIIa receptor with tirofiban in unstable angina and non Q wave myocardial infartion
8. A phase II study of temozolamide vs. procarbazine in patients with glioblastoma multiforme at first relapse
9. Humanized monoclonal antibody for prevention of respiratory syncytial virus infections
10. User's guides to the medical literature. Integrating research evidence with the care of individual patient
11. The number needed to treat: A clinically useful measure of treatment effect
12. El número de pacientes que será necesario tratar: Una herramienta de interés para el clínico
13. Numbers needed to treat derived from meta-analyses-sometimes informative, usually misleading
14. Does evidence-based medicine help the development of clinical practice guidelines?
15. Using clinical guidelines
16. Getting research findings into practice. When to act on the evidence
17. Potential benefits, limitations, and harms of clinical guidelines
18. Healthcare rationing-are additional criteria needed for assessing evidence based clinical practice guidelines?
19. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban
20. Guidelines for clinical guidelines